ArticleTranslational psychiatry2026
Loss of connexin 36 elicits abnormalities in thalamocortical network activity relevant to neuropsychiatric disorders.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Defining the electrical synapse.Nature reviews. Neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Neuronal gap junctions, or electrical synapses, are extensively expressed in the mammalian forebrain and play a key role in synchronizing network activity. Connexin 36 (Cx36) is the primary gap junction protein in mature GABAergic neurons, but its contribution to thalamocortical oscillations and cognitive processes remains unclear. Here, we examined the effects of Cx36 deletion on sleep/wake regulation, spontaneous and evoked EEG activity, and behavior in mice. While Cx36 knockout (KO) mice displayed largely intact sleep architecture, spectral analysis revealed impaired gamma and beta band activity and reduced sigma power surges preceding NREM-REM transitions. Spindle density was preserved, but spindle amplitude and duration were reduced. Cx36KO mice exhibited blunted gamma responses to ketamine, impaired 40 Hz auditory steady-state responses, and reduced mismatch negativity with attenuated ERP amplitudes and altered evoked power. Behaviorally, Cx36KO mice showed impaired social habituation and reduced investigation-induced gamma activity. These findings demonstrate that Cx36-containing gap junctions are essential for maintaining thalamocortical synchrony and support translational EEG biomarkers relevant to schizophrenia and other psychiatric disorders. Cx36 may therefore represent a novel therapeutic target for modulating dysfunctional network activity in neuropsychiatric disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.